Preparation and application of traditional Chinese medicine chemical component with colon cancer resisting activity
By extracting rupestrin B from the squid grass, a low-cost, strong anti-colorectal cancer activity in traditional Chinese medicine was prepared, which solved the problem of weak research on colorectal cancer treatment drugs, and provided a natural anti-correlation with small side effects and significant effects Tumor drug raw materials.
Patent Information
- Application Number
- CN202410848049.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-06-27
- Publication Date
- 2024-11-08
Smart Images

Figure BCIZIKYI06KQXYEAEZ8F6W6MCPSWTSCVW8SVHYGS 
Figure VODKNCOTAJXCZ7U6JJFDZM63USCEIYITDST0UTJJ
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of natural anti-tumor drug development, and specifically relates to the preparation and application of a traditional Chinese medicine chemical component with anti-colorectal cancer activity. Background Art
[0002] Colorectal cancer is one of the most common malignant tumors in my country. The data on the incidence and mortality of malignant tumors in China in 2022 recently released by the National Cancer Center show that the incidence of colorectal cancer is second only to lung cancer, up to 517,000 cases, and the mortality rate is also fourth, up to 240,000 cases, and the number of patients is increasing year by year, which is a serious situation. The 5-year survival rate of colorectal cancer is only 14%. The generally accepted treatment regimen is mainly a treatment mode of surgery combined with chemotherapy and EGFR / VEGF inhibitors, but this regimen still has a high failure rate for patients in the middle and late stages. In recent years, with the introduction of the concept of precision treatment and the development of molecular pathology, new targets have been discovered or new drugs have been launched. At present, targeted drugs and immune checkpoint inhibitors have become important breakthroughs for highly heterogeneous colorectal cancer, but so far these different molecular typings of omics cannot correspond to each other, and there is no clinically applicable typing. Immunotherapy has also been a research hotspot in recent years. Antibodies alone or in combination with other treatments have achieved good results in advanced cancer, providing hope for a small number of patients. At present, immunotherapy is only applicable to colorectal cancer cases with dMMR / MSI-H and PLOE / POLD1, and the cases that can actually benefit from immunotherapy do not exceed 5% of the total. Therefore, the research on therapeutic drugs for colorectal cancer is still a very difficult problem. Compared with Western medical treatments for colon cancer, traditional Chinese medicine treatments have the advantages of safety, effectiveness, and fewer adverse reactions. Surveys have shown that more than half of innovative drugs come from natural medicines. Therefore, the development and utilization of traditional Chinese medicine is conducive to alleviating patients' pain and serving the society.
[0003] Spotted grass[ Bothriospermum Bge. chinense, also known as fine-stemmed spotted grass, is a plant of the genus Bge. of the Boraginaceae family. It is slightly bitter and astringent, flat in nature, and slightly toxic. The National Compilation of Chinese Herbal Medicines records that it has the effects of detoxification, swelling, dampness and itching. However, there are few studies on the modern pharmacology and active ingredients of Bge. There is no modern research on anti-colon cancer. Therefore, the present invention is of far-reaching significance, has broad prospects, and is worth promoting.
[0004] In addition, Yangzhou City, Jiangsu Province and Guanzhong and other areas conducted a survey on the harm of wheat field weeds. The results showed that there were spotted grass, which itself was not harmful and had certain medicinal value, but was regarded as a weed that harmed farmland, subverting the medicinal value of spotted grass. As a medicinal material included in the "National Compilation of Chinese Herbal Medicines", it has now fallen into the ranks of weeds and lost its use. If the spotted grass can be studied as soon as possible, the mechanism can be clarified, its efficacy can be determined, and its value can be realized, it can not only turn weeds into treasures, reduce the burden of agriculture, and reduce the environmental pollution caused by excessive use of pesticides, but also provide a scientific basis for modern clinical medication, achieving multiple goals at one stroke and having far-reaching significance. According to the investigation of the research team, it can be judged that the number of wild spotted grass is huge, and it is also quite difficult in the process of weed removal in farmland. Excessive use of herbicides not only has great harm to the wheat field itself, but also has a great increase in environmental pollution, and the problem is very serious. The content of the present invention can not only solve the "weed problem", but also benefit environmental protection, and can drive local economic development, and provide a large number of cheap and effective Chinese medicinal materials for clinical use. Summary of the invention
[0005] In response to the problems raised by the background technology, the present invention studies and designs a preparation method of a Chinese herbal chemical component with anti-colorectal cancer activity and its application, and its purpose is to provide a preparation method of a Chinese herbal chemical component with anti-colorectal cancer activity with simple extraction and separation process, low cost, strong anti-colorectal cancer activity, small side effects and huge development potential and its application.
[0006] A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity comprises the following steps: 1. Extraction: Take the dried whole herb of the Herba Lycopodii, cut it into sections, sieve it to remove the soil residue, add 8-12 times the amount of solvent per kilogram of the whole herb of the Herba Lycopodii, and reflux extract it at a constant temperature for 2-4 times, each time for 1-2.5 hours to obtain the solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 3-8 times the weight of the concentrate obtained in step 1 to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, and add 2-4 times the volume of petroleum ether to extract 2-4 times, combine the petroleum ether extracts, extract the obtained water layer with 2-4 times the volume of ethyl acetate 2-4 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography, with gradient elution of methanol-water (10%→100%), and detected by thin layer chromatography. 20 fractions were combined, and fraction 12 was subjected to high pressure preparative liquid chromatography to obtain a compound, which is the Chinese medicinal chemical component with anti-colorectal cancer activity of the present invention.
[0007] Preferably, in the step 1, the length of the segments after cutting is 1-3 cm, and the sieve is a No. 1 sieve (10 mesh).
[0008] Preferably, the solvent in step 1 is one of 95% ethanol, 75% ethanol and methanol.
[0009] Preferably, in the step 1, 10 liters of extraction solvent is added for every kilogram of the whole herb of Herba Lycopodii, and the extraction is performed by constant temperature reflux for 3 times, with each reflux for 1.5 hours.
[0010] Preferably, the constant temperature in step 1 is 80°C.
[0011] Preferably, in the step 2, distilled water 5 times the weight of the concentrate obtained in the step 1 is added for suspension, and an ultrasonic oscillator is used to assist the suspension to obtain a suspension, and petroleum ether 2 times the volume of the suspension is added for extraction 3 times, and the obtained water layer is extracted 3 times with 2 times the volume of ethyl acetate.
[0012] Preferably, the fraction 12 in the step three is subjected to high pressure preparative liquid chromatography, and the preparation conditions are: select a SUNNIST PFP&C18 column, the mobile phase is 40% methanol: 60% FA water, the flow rate is set to 2 mL / min, the injection volume is set to 10 μL, and the peak is collected at 8.93 min-9.86 min to obtain a compound, which is the Chinese medicine chemical component with anti-colorectal cancer activity of the present invention.
[0013] The application of the chemical components of traditional Chinese medicine for preparing anti-colorectal cancer prepared by the above method is used to develop anti-colorectal cancer drugs.
[0014] Beneficial effects of the present invention: the extract of the present invention is prepared from the whole herb of the single dried herb of the herb of the herb of the herb of the Boraginaceae family (from the fields of Caoji Township, Suyu District, Suqian City, Jiangsu Province, identified as the herb of the herb of the herb of the Boraginaceae family by Huang Yunfeng, a researcher of Guangxi Traditional Chinese Medicine Research), through the steps of reflux, extraction, concentration, separation, etc., and the extraction and separation process is simple and the cost is low. The results of Popper detection and CCK8 experiments show that the Chinese medicinal chemical component separated from the ethyl acetate extract of the herb of the present invention is rupestrin B, which has a certain inhibitory effect on the proliferation of colorectal cancer SW620 cells, and its IC 50 0.33 μmol·L -1 . BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 The diagram is a molecular structure diagram of the chemical components of the traditional Chinese medicine with anti-colorectal cancer activity of the present invention. DETAILED DESCRIPTION
[0016] The following is a description of the implementation of the present invention by means of specific embodiments. Those skilled in the art can easily understand other advantages and effects of the present invention from the contents disclosed in this specification.
[0017] In the embodiments of the present invention, the whole herb of Scutellaria scabra found in the fields of Caoji Township, Suyu District, Suqian City, Jiangsu Province was identified as Scutellaria scabra, a plant of the Boraginaceae family, by researcher Huang Yunfeng of Guangxi Traditional Chinese Medicine Research.
[0018] Example 1 1. Extraction: Take the dried whole herb of the herb, cut it into 1.5 cm long segments, pass it through a No. 1 sieve to remove the soil residue, add 10 times the amount of 95% ethanol extraction solvent per kilogram of medicinal material, and reflux extract at 80°C for 3 times, each time for 2 hours to obtain a 95% ethanol solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 8 times the weight of the concentrate in step 1 to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, and add 1.5 times the volume of petroleum ether to extract 3 times, combine the petroleum ether extracts, extract the obtained water layer with 1.5 times the volume of ethyl acetate 3 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography with methanol-water (10%→100%) gradient elution, and detected by thin layer chromatography. 20 fractions were obtained, and the high pressure preparative liquid chromatography conditions of fraction 12 were as follows: SUNNIST PFP&C18 column was selected, the mobile phase was 40% methanol: 60% FA water, the flow rate was set to 2 mL / min, the injection volume was set to 10 μL, and the peak was collected at 8.93 min-9.86 min to obtain the compound, which is the Chinese medicinal chemical component with anti-colorectal cancer activity of the present invention.
[0019] Example 2 1. Extraction: Take the dried whole herb of the herb, cut it into 1 cm long segments, pass it through a No. 1 sieve to remove the soil residue, add 8 times the amount of 75% ethanol extraction solvent per kilogram of medicinal material, and reflux extract it at a constant temperature for 2 times, each time for 1 hour, to obtain a 75% ethanol solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 6 times the weight of the concentrate in step 1 to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, and obtain a suspension. Add 4 times the volume of petroleum ether to extract twice, combine the petroleum ether extracts, extract the obtained water layer with 4 times the volume of ethyl acetate for 3 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography, with methanol-water (10%→100%) gradient elution, detected by thin layer chromatography, and 20 fractions were obtained. The high pressure preparative liquid chromatography conditions of fraction 12 were: SUNNIST PFP&C18 column was selected, the mobile phase was 40% methanol: 60% FA water, the flow rate was set to 2mL / min, the injection volume was set to 10μL, and the peak was collected at 8.93min-9.86min to obtain the compound, which is the Chinese medicine chemical component with anti-colorectal cancer activity of the present invention.
[0020] Example 3 1. Extraction: Take the dried whole herb of the herb, cut it into 2 cm long segments, pass it through a No. 1 sieve to remove the soil residue, add 9 times the amount of 95% ethanol extraction solvent per kilogram of medicinal material, and perform constant temperature reflux extraction 3 times, each time for 2 hours to obtain a 95% ethanol solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 7 times the weight of the concentrate to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, and obtain a suspension. Add 2 times the volume of petroleum ether to extract 3 times, combine the petroleum ether extracts, extract the obtained water layer with 2 times the volume of ethyl acetate 3 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography with methanol-water (10%→100%) gradient elution, and detected by thin layer chromatography. 20 fractions were obtained, and the high pressure preparative liquid chromatography conditions of fraction 12 were as follows: SUNNIST PFP&C18 column was selected, the mobile phase was 40% methanol: 60% FA water, the flow rate was set to 2 mL / min, the injection volume was set to 10 μL, and the peak was collected at 8.93 min-9.86 min to obtain the compound, which is the Chinese medicinal chemical component with anti-colorectal cancer activity of the present invention.
[0021] Example 4 1. Extraction: Take the dried whole herb of the herb, cut it into 3 cm long segments, pass it through a No. 1 sieve to remove the soil residue, add 9 times the amount of methanol extraction solvent per kilogram of medicinal material, and extract it under constant temperature reflux for 4 times, each time for 2.5 hours to obtain a methanol solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 5 times the weight of the concentrate in step 1 to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, add 3 times the volume of petroleum ether to extract 4 times, combine the petroleum ether extracts, extract the obtained water layer with 3 times the volume of ethyl acetate 3 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography with methanol-water (10%→100%) gradient elution, and detected by thin layer chromatography. 20 fractions were obtained, and the high pressure preparative liquid chromatography conditions of fraction 12 were as follows: SUNNIST PFP&C18 column was selected, the mobile phase was 40% methanol: 60% FA water, the flow rate was set to 2 mL / min, the injection volume was set to 10 μL, and the peak was collected at 8.93 min-9.86 min to obtain the compound, which is the Chinese medicinal chemical component with anti-colorectal cancer activity of the present invention.
[0022] Example 5 Anti-colorectal cancer activity detection experiment: The CCK8 method was used to detect cell proliferation. The samples were dissolved into a 10 mmol·L-1 stock solution with cell culture grade DMSO and stored at low temperature. The concentration of DMSO in the final system was controlled within the range that did not affect the detection activity, and the dilution ratio was 0.1~20 μmol·L-1. The above cancer cells in the logarithmic growth period were taken and a single cell suspension of 1×106 cells / mL was prepared with L-15 (SW620) containing 10% calf serum. The suspension was added to a 96-well plate, and 100 μL was added to each well. After culturing in a 5% CO2, 37 ℃ incubator for 24 h, various concentrations of test compounds and positive control drug oxaliplatin were added to make the final concentrations 0.3 n mmol·L-1~20 μmol·L-1, respectively. Three replicates were set for each sample, and the negative control was an equal volume of culture medium and the corresponding DMSO concentration as a solvent control to eliminate the effect of DMSO on cell growth. After incubation in a 5% CO2, 37 ℃ incubator for 72 h, 10 μL of CCK8 solution was added to each well. After incubation (37 ℃, 5% CO2) for 40-60 min, the absorbance (OD) at 450 nm was measured using a microplate reader. The inhibition rate was calculated using the measured OD value, and the IC50 value of the compound was fitted using Graphpad Prism 8 software.
[0023] Through spectroscopy analysis, the molecular structure of the compound of the present invention was obtained, as shown in FIG1 .
[0024] The results of anti-colorectal cancer activity test are shown in Table 1. It can be seen from Table 1 that the Chinese medicinal chemical components of the present invention have a strong ability to eliminate the proliferation of colorectal cancer SW620 cells. 50 0.33 μmol·L -1 .
[0025] Table 1 The results of the inhibitory effect of the chemical components of the present invention on the proliferation of SW620 cells The invented product can be used for the research and development of new drugs against colorectal cancer. It is the active ingredient of the traditional Chinese medicine Herba Lycopodii that has the effect of fighting colorectal cancer. Providing raw materials for the development of natural anti-tumor drugs is the main technical problem it solves. The product of the invention has strong anti-colorectal cancer activity, has a strong inhibitory effect on the proliferation of SW620 cells, and is non-toxic to normal colon cells. It is an important component of natural anti-tumor drugs that are widely used and studied at home and abroad. The product of the invention is a natural active ingredient of traditional Chinese medicine, has strong anti-colorectal cancer activity, few side effects, and huge development potential.
[0026] The above embodiments only illustrate specific implementations of the present disclosure, but the implementations of the present disclosure are not limited by the above contents. Any changes, modifications, substitutions, combinations, and simplifications made without substantially departing from the main idea and principle of the inventive concept of the present disclosure shall be equivalent replacement methods and shall be included in the scope of protection determined by the claims.
Claims
1. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity, characterized in that: The steps include:
1. Extraction: Take the dried whole herb of the Herba Lycopodii, cut it into sections, sieve it to remove the soil residue, add 8-12 times the amount of solvent per kilogram of the whole herb of the Herba Lycopodii, and reflux extract it at a constant temperature for 2-4 times, each time for 1-2.5 hours to obtain the solvent extract, combine the extracts, and concentrate under reduced pressure to obtain a concentrate; 2. Extraction: add 3-8 times the weight of the concentrate obtained in step 1 to suspend with distilled water, use an ultrasonic oscillator to assist the suspension, and add 2-4 times the volume of petroleum ether to extract 2-4 times, combine the petroleum ether extracts, extract the obtained water layer with 2-4 times the volume of ethyl acetate 2-4 times, combine the ethyl acetate extracts, and recover the solvent under reduced pressure to obtain an ethyl acetate extract; 3. Separation: The ethyl acetate extract was separated by reverse phase ODS medium pressure chromatography, with gradient elution of methanol-water (10%→100%), and detected by thin layer chromatography. 20 fractions were combined, and fraction 12 was subjected to high pressure preparative liquid chromatography to obtain a compound, which is the Chinese medicinal chemical component with anti-colorectal cancer activity of the present invention.
2. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: The length of the segments after cutting in step 1 is 1-3 cm, and the sieve is a No. 1 sieve (10 mesh).
3. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: The solvent in step 1 is one of 95% ethanol, 75% ethanol and methanol.
4. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: In the step 1, 10 liters of extraction solvent is added to every kilogram of the whole herb of Herba Lycopodii, and constant temperature reflux extraction is performed for 3 times, with each reflux for 1.5 hours.
5. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: The constant temperature in step 1 is 80°C.
6. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: In the step 2, distilled water 5 times the weight of the concentrate obtained in the step 1 is added for suspension, and an ultrasonic oscillator is used for suspension assistance to obtain a suspension, and petroleum ether 2 times the volume of the suspension is added for extraction 3 times, and the obtained water layer is extracted 3 times with 2 times the volume of ethyl acetate.
7. A method for preparing a Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1, characterized in that: The fraction 12 in the step 3 was subjected to high pressure preparative liquid chromatography, and the preparation conditions were: a SUNNIST PFP&C18 column was selected, the mobile phase was 40% methanol: 60% FA water, the flow rate was set to 2 mL / min, the injection volume was set to 10 μL, and the peak was collected at 8.93 min-9.86 min to obtain a compound, which is the Chinese medicine chemical component with anti-colorectal cancer activity of the present invention.
8. Use of the Chinese medicinal chemical component having anti-colorectal cancer activity as claimed in claim 1 in developing anti-colorectal cancer drugs.
Citation Information
Patent Citations
Preparation and application of traditional Chinese medicine extract for preparing antioxidant
CN114796048A
Application of botrychium variegatum extract in preparation of antitumor drugs
CN116712475A
